Mallinckrodt plc Files 8-K on Shareholder Vote Matters
| Field | Detail |
|---|---|
| Company | Mallinckrodt PLC |
| Form Type | 8-K |
| Filed Date | Oct 9, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $0.001, $10,000,000, $3,005,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: MNK
TL;DR
MNK filed an 8-K for a shareholder vote on Oct 8th. Routine stuff.
AI Summary
Mallinckrodt plc filed an 8-K on October 9, 2025, reporting on a submission of matters to a vote of security holders that occurred on October 8, 2025. The filing details standard corporate governance procedures without disclosing specific financial transactions or significant business events.
Why It Matters
This filing indicates routine corporate governance activity, such as shareholder votes, which are standard for publicly traded companies and typically do not represent a significant change in business operations.
Risk Assessment
Risk Level: low — The filing pertains to standard corporate governance procedures and does not indicate any new risks or material changes to the company's operations or financial standing.
Key Players & Entities
- Mallinckrodt plc (company) — Registrant
- October 8, 2025 (date) — Date of Earliest Event Reported
- October 9, 2025 (date) — Date of Report
FAQ
What specific matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders on October 8, 2025, but does not specify the nature of these matters in the provided text.
What is the Commission File Number for Mallinckrodt plc?
The Commission File Number for Mallinckrodt plc is 001-35803.
Where is Mallinckrodt plc's principal executive office located?
Mallinckrodt plc's principal executive office is located at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.
What is the IRS Employer Identification No. for Mallinckrodt plc?
The IRS Employer Identification No. for Mallinckrodt plc is 98-1088325.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 678 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2025-10-09 16:08:24
Key Financial Figures
- $0.01 — b-division of the Preferred Shares of US$0.01 each in the authorized share capital of
- $0.001 — allinckrodt into Preferred Shares of US $0.001 each. 30,962,466 1,000,495 253,326
- $10,000,000 — f Resolution 2(a) above will stand at US$10,000,000 and 25,000 divided into 500,000,000 Ord
- $3,005,000,000 — hare capital of Mallinckrodt shall be US$3,005,000,000 and 25,000 divided into 500,000,000 Ord
Filing Documents
- tm2528043d2_8k.htm (8-K) — 35KB
- 0001104659-25-098351.txt ( ) — 196KB
- mnk-20251008.xsd (EX-101.SCH) — 3KB
- mnk-20251008_lab.xml (EX-101.LAB) — 33KB
- mnk-20251008_pre.xml (EX-101.PRE) — 22KB
- tm2528043d2_8k_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On October 8, 2025, Mallinckrodt plc (" Mallinckrodt " or the " Company ") held an extraordinary general meeting of shareholders (the " EGM ") to vote on matters outlined in Mallinckrodt's proxy statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission on August 20, 2025. As of the close of business (Eastern Time in the United States) on September 5, 2025, the record date for the shareholders entitled to vote at the EGM, there were a total of 39,421,403 issued and outstanding Mallinckrodt ordinary shares. A quorum was present at the EGM. Each resolution proposed at the EGM was approved by the requisite vote of Mallinckrodt's shareholders. The final results of voting on each of the items submitted to a vote of Mallinckrodt's shareholders at the EGM are as follows. Resolution For Against Abstain Broker Non-Vote Resolution 1 : Approve the change of the name of Mallinckrodt from Mallinckrodt plc to Keenova Therapeutics plc. 34,853,246 49 165,706 0 Resolution 2 : Resolution 2(a) : Approve the sub-division of the Preferred Shares of US$0.01 each in the authorized share capital of Mallinckrodt into Preferred Shares of US $0.001 each. 30,962,466 1,000,495 253,326 2,802,714 Resolution 2(b) : Approve a variation and increase in the authorized share capital of Mallinckrodt, which following the approval of Resolution 2(a) above will stand at US$10,000,000 and 25,000 divided into 500,000,000 Ordinary Shares of US $0.01 each, 5,000,000,000 Preferred Shares of US$0.001 each and 25,000 Ordinary A Shares of 1.00 each, by the creation of 2,995,000,000,000 new Preferred Shares of US$0.001 each, such that the authorized share capital of Mallinckrodt shall be US$3,005,000,000 and 25,000 divided into 500,000,000 Ordinary Shares of US$0.01 each, 3,000,000,000,000 Preferred Shares of US$0.001 each and 25,000 Ordinary A Shares of 1.00 each. 30,931,290 1,044,510 240,487 2,8
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MALLINCKRODT PLC Date: October 9, 2025 By: /s/ Mark Tyndall Name: Mark Tyndall Title: Executive Vice President and Chief Legal Officer & Corporate Secretary -3-